Research and experimental development on natural sciences and engineering
GENO R&D AS
Revenue 2024
NOK 18.9m
Operating profit
NOK −57,000
Equity
NOK 1.8m
Incorporated
2008
Share capital
NOK 900,000
Key figures · 2024
Current ratio
1.12
Equity ratio
11.0%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -0.3% | |
| Net margin (%%) | 0.9% | |
| Return on assets (%%) | -0.4% | |
| Likviditet | ||
| Current ratio | 1.12 | |
| Working capital | 1.8m | |
| Soliditet | ||
| Equity ratio (%%) | 11.0% | |
| Debt-to-equity ratio | 8.08 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.